Overview
- Government data on Wednesday reported about 6,186 confirmed Ebola cases and 3,007 laboratory‑confirmed deaths in eastern Democratic Republic of Congo, with the epidemic concentrated in Ituri and other northeastern provinces.
- Genetic testing shows the outbreak is driven by the rare Bundibugyo ebolavirus for which there is no licensed strain‑specific vaccine or proven therapy.
- Authorities have begun emergency use of the Ervebo vaccine for frontline workers while clinical trials of Bundibugyo‑targeted vaccines and treatments are being launched; results will take months.
- Independent evaluations from the U.S. CDC and Africa CDC warn that contact tracing and case detection remain below targets, with many transmission chains undetected because of insecurity, attacks on health teams, health worker strikes and high population movement.
- WHO has urged immediate, large‑scale funding and operational support for a government plan seeking roughly $1.3 billion to scale testing, care, trials and community engagement to prevent further spread to neighbouring countries.